Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists at Hospital Discharge

Recruiting N/A Interventional Study
Polypharmacy
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
150 (estimated)
Sponsor
Pharmacie des Hopitaux de l'Est Lemanique · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this study is to evaluate the impact of an enhanced collaboration between a hospital pharmacist and a community pharmacist during hospital discharge. For patients taking multiple medications, hospitalization often involves numerous changes to their treatment regimen. For community pharmacies, discharge prescriptions are often complex, and they sometimes lack the information that pharmac…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients admitted to the internal medicine ward for more than 48 hours * Patients prescribed seven or more drugs at the time of screening * Patients discharged to home * Patients able to give informed consent as documented by signature Exclusion Criteria: * Patient discharge…
Contacts

Paul Garin, PharmD

+41 79 534 21 36

paul.garin@phel.ch

CONTACT

Anne-Laure Blanc, PharmD, PhD

+41 58 773 45 43

annelaure.blanc@phel.ch

CONTACT